Donald L. Hagan, LLC Amgen Inc Transaction History

Donald L. Hagan, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$230.71 - $256.74 $382,286 - $425,418	-1,657 Closed	0 $0
Q1 2022 Apr 18, 2022	SELL	$219.27 - $242.57 $5,043 - $5,579	-23 Reduced 1.37%	1,657 $401,000
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $17,501 - $20,028	88 Added 5.53%	1,680 $378,000
Q3 2021 Oct 20, 2021	BUY	$212.27 - $248.7 $337,933 - $395,930	1,592 New	1,592 $339,000
Q3 2020 Oct 16, 2020	SELL	$234.65 - $260.95 $1.11 Million - $1.24 Million	-4,750 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$197.81 - $242.74 $130,356 - $159,965	-659 Reduced 12.18%	4,750 $1.12 Million
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $985,736 - $1.31 Million	5,409 New	5,409 $1.2 Million
Q4 2019 Jan 24, 2020	SELL	$189.21 - $243.2 $202,833 - $260,710	-1,072 Closed	0 $0
Q3 2019 Oct 21, 2019	BUY	$174.11 - $208.62 $186,645 - $223,640	1,072 New	1,072 $218,000
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $189,370 - $213,462	-1,047 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $193,998 - $218,707	1,047 New	1,047 $217,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Donald L. Hagan, LLC, based on Form 13F filings with the SEC.

Stay updated on Donald L. Hagan, LLC with notifications on news.